Christopher J. Wohlberg

Dr. Wohlberg is a clinician and product development specialist with 30 years of experience in clinical neurology and the pharmaceutical / biotechnology industry. Board certified in Psychiatry and Neurology, he was involved in multiple areas of CNS and cardiovascular drug development over 20 years at Pfizer. He served as the Medical Director for Zoloft, Macugen, and later, Lyrica. In those roles, Dr. Wohlberg oversaw the medical team, developed the portfolio strategy for the therapeutics, provided medical support for the country medical and regulatory issues, and supported marketing support for the indication as well as support for the key opinion leaders.